Venom Immunotherapy: From Proteins to Product to Patient Protection

por Feindor, Martin, Heath, Matthew D., Hewings, Simon J., Carreno Velazquez, Thalia L., Blank, Simon, Grosch, Johannes, Jakob, Thilo, Schmid-Grendelmeier, Peter, Klimek, Ludger, Golden, David B. K., Skinner, Murray A., Kramer, Matthias F.
Publicado 2021

First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma underg...

por Pfeiffer, Norbert, Voykov, Bogomil, Renieri, Giulia, Bell, Katharina, Richter, Paul, Weigel, Melanie, Thieme, Hagen, Wilhelm, Barbara, Lorenz, Katrin, Feindor, Martin, Wosikowski, Katja, Janicot, Michel, Päckert, Daniela, Römmich, Regina, Mala, Carola, Fettes, Petra, Leo, Eugen
Publicado 2017